What's New

Antimicrobial Resistance : WHO Report

News: The latest WHO study cites shortcomings in ensuring a strong pipeline of antibiotic medicines while also highlighting improvements in the fight against antimicrobial resistance (AMR).

AMR is the term used to describe a microorganism’s capacity to withstand the effects of antimicrobial treatments such as antibiotics, antivirals, antifungals, and antiparasitic medications. For instance, the New Delhi metallo–lactamase (NDM-1) superbug AMR is expected to kill over 2 million people in India alone by the year 2050. In 2019, it was responsible for approximately 5 million fatalities worldwide. Access to current therapies is still a problem, and the production of new antibiotics is constrained.

AMR is still one of the top 10 worldwide public health dangers to humans, according to the report.

Children under the age of five made up one in five of those who died from AMR.

By 2050, AMR could have cost the global economy USD 100 trillion if nothing is done.

The report makes the following recommendations: increased spending on R&D; coordination of financial structures; and international initiatives to guarantee equal access to antibiotics.